A mechanism-driven treatment for chronic lymphocytic leukemia?
- PMID: 23782159
- DOI: 10.1056/NEJMe1303054
A mechanism-driven treatment for chronic lymphocytic leukemia?
Comment on
-
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.N Engl J Med. 2013 Jul 4;369(1):32-42. doi: 10.1056/NEJMoa1215637. Epub 2013 Jun 19. N Engl J Med. 2013. PMID: 23782158 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources